The prevention of contrast medium-induced acute kidney injury is a major challenge for interventional cardiologists. Several patient and procedure-associated risk factors were identified in previous studies. Only a few contrast medium-induced acute kidney injury prevention strategies exist. Ischemic preconditioning has been shown in the RenPro (Renal Protection) Trial to be an effective, safe, and economic method for prevention of contrast medium-induced acute kidney injury in high-risk patients. The broad application of this method in daily clinical settings may remarkably influence the cardiovascular outcome in high-risk patients.
Incidence of Infective Endocarditis Caused by Viridans Group Streptococci Before and After Publication of the 2007 American Heart Association's Endocarditis Prevention Guidelines
Summary: Infective endocarditis (IE) is an uncommon but potentially lethal infection. Although there are no randomized trials to support its efficacy, antibiotic prophylaxis administered before certain dental procedures in patients with specific underlying cardiac conditions has been advocated since 1955 by the American Heart Association in IE prevention guidelines. The updated 2007 American Heart Association guidelines included a marked reduction in the cardiac conditions that warranted antibiotic prophylaxis for certain dental procedures. Despite these recommendations and the lack of evidence for antibiotic prophylaxis administration, there has been sustained concern among some healthcare personnel about an increase in IE cases caused by viridans group streptococci because of the limitation of antibiotic prophylaxis use. In response to these concerns, the current population-based survey was conducted to determine whether the incidence of viridans group streptococci-IE had increased in Olmsted County, Minnesota, since the publication of the 2007 American Heart Association IE prevention guidelines. Results demonstrated no observed increase in this population-based cohort. Moreover, data from a national inpatient database support this finding. Nevertheless, limitations of the study, including a small annual number of IE cases, mandate continued evaluation of incidence trends over an extended period of time, both locally and elsewhere, before concerns regarding increasing incidence of viridans group streptococci-IE related to changes in guidelines recommendations can be addressed fully.
Conclusions: On the basis of data complete through 2010, there has been no perceivable increase in the incidence of VGS-IE in Olmsted County, Minnesota, since the publication of the 2007 American Heart Association endocarditis prevention guidelines. 1
Western-Style Fast Food Intake and Cardiometabolic Risk in an Eastern Country
Summary: With globalization, Western-style fast food intake is becoming more common in developing and recently developed areas of the world. Despite being widely linked with poor cardiometabolic health in both popular and scientific press, few studies have directly examined Western-style fast food intake and cardiometabolic risk, making this connection largely speculative. Furthermore, there is a lack of research examining the association of Western-style fast food intake with any outcomes in populations outside the United States. We therefore examined the associations between Western-style fast food intake habits and risk of incident type 2 diabetes mellitus and coronary heart disease mortality in a cohort of middle-aged and older Chinese men and women in the Singapore Chinese Health Study. Participants who reported more frequent intake of Western-style fast food were younger, less likely to be hypertensive, and more educated; smoked less; and were more physically active. In models with full adjustment for demographic, lifestyle, and dietary factors, Chinese Singaporeans with relatively frequent intake of Western-style fast food items (≥2 times per week) had a 27% increased risk of developing type 2 diabetes mellitus and a 56% increased risk of dying of coronary heart disease relative to their peers with little or no reported intake. These associations were not materially altered by adjustments for overall dietary pattern, energy intake, and body mass index. Overall, these findings suggest the need for further attention to global dietary acculturation in the context of ongoing epidemiological and nutrition transitions.
Conclusions: Western-style fast food intake is associated with increased risk of developing type 2 diabetes mellitus and of coronary heart disease mortality in an Eastern population. These findings suggest the need for further attention to global dietary acculturation in the context of ongoing epidemiological and nutrition transitions. 2
Ischemic Preconditioning for Prevention of Contrast Medium-Induced Nephropathy: Randomized Pilot RenPro Trial (Renal Protection Trial)

Statins and the Risk of Cancer After Heart Transplantation
Summary: Although newer immunosuppressive agents have lowered the incidence of malignancies after transplantation, cancer remains a leading cause of death late after heart transplantation. Because statins are immunomodulatory drugs and reduce the incidence of rejection and improve survival after cardiac transplantation, the present study investigated whether statin therapy impacts cancer risk as well as cancer-free and total mortality in heart transplant recipients. During follow-up, a malignancy was diagnosed in 108 patients (42%). Interestingly, the cumulative incidence of any malignancy was reduced in patients receiving a statin 8 years after transplantation (34% versus13%, P=0.003), and the benefit persisted at the 10-year and 12-year follow-up. In addition, statin use was associated with improved cancer-free and overall survival (both P<0.0001). Statins reduced the hazard of occurrence of any malignancy by 67% (hazard ratio, 0.33; P<0.0001). A Cox regression model that analyzed the time to tumor formation with or without statin therapy, adjusted for age, male sex, type of cardiomyopathy, and immunosuppressive therapy (including switching to mTOR [mammalian target of rapamycin] inhibitors or tacrolimus), demonstrated a decreased hazard for tumor formation in the statin group. Thus, in spite of limitations in adjusting for all potential confounders over a follow-up period of up to 25 years, during which factors related to the era of transplantation (such as overall intensity of immunosuppression and use of azathioprine) might have changed, the results of the present study suggest that statin use is associated with a substantial reduction of cancer risk and all-cause mortality in heart transplant recipients. Whether these benefits of statins are specific for heart transplant recipients who are at particularly high risk of cancer or can be extrapolated to all patients undergoing long-term immunosuppressive therapy (particularly with tacrolimus and mTOR inhibitors) needs to be confirmed in long-term randomized clinical trials.
Conclusions:
Although it is not possible to adjust for all potential confounders because of the very long follow-up period, this registry suggests that statin use is associated with improved cancer-free and overall survival after cardiac transplantation. These data will need to be confirmed in a prospective trial. 4
Adult Bone Marrow Cell Therapy Improves Survival and Induces Long-Term Improvement in Cardiac Parameters: A Systematic Review and Meta-Analysis
Summary: Although adult bone marrow cell (BMC) therapy for cardiac repair appears promising, divergent data from smaller clinical trials have generated lingering controversy over the nature and extent of benefits. We performed a systematic review and meta-analysis of pooled data from 50 trials to assess the impact of BMC therapy on clinically important end points. Our results show that BMC therapy modestly improves left ventricular function and remodeling in patients with ischemic heart disease and that these benefits persist during long-term follow-up. These data also suggest that BMC therapy is associated with reduced all-cause and cardiac mortality and reduced incidence of recurrent myocardial infarction and stent thrombosis without any significant increase in adverse events. BMC therapy seems effective for both acute myocardial infarction and chronic ischemic cardiomyopathy, largely independently of the location of myocardial infarction. Patients with lower left ventricular ejection fraction at baseline appear to benefit more. To be effective, injection of at least 40 million BMCs seems necessary, and the remodeling benefits seem more pronounced with earlier BMC injection. Although BM mononuclear cells are generally more effective compared with subpopulations, cell processing techniques deserve particular attention because they influence the outcomes significantly. Finally, the magnitude of changes in various outcome parameters depends on the imaging modality, although the findings remain directionally concordant. Thus, larger clinical trials using stringent methodology and a broader array of outcomes are warranted to definitively determine the true utility of this novel therapeutic strategy for cardiac repair.
Conclusions: Transplantation of adult BMCs improves LV function, infarct size, and remodeling in patients with ischemic heart disease compared with standard therapy, and these benefits persist during long-term follow-up. BMC transplantation also reduces the incidence of death, recurrent myocardial infarction, and stent thrombosis in patients with ischemic heart disease. 5
Left Bundle-Branch Block Induced by Transcatheter Aortic Valve Implantation Increases Risk of Death
Summary: Transcatheter aortic valve implantation (TAVI) has proved to be a valuable treatment in patients with severe, symptomatic aortic valve stenosis who do not qualify for surgery. The TAVI procedure is frequently complicated by new-onset left bundle-branch block (LBBB). Although this complication has been addressed in TAVI literature, no attention has been paid to its clinical relevance, despite ample evidence of unfavorable outcome in other patient populations. Our multicenter study, comprising 679 TAVI patients from 8 centers in the Netherlands, convincingly shows that TAVI-induced LBBB is one of the strongest predictors of all-cause mortality. The observed ≈60% increase in mortality caused by TAVI-induced LBBB suggests that the benefit of valve repair is largely neutralized when LBBB develops. Mortality risk of LBBB was independent of the device type used; however, the incidence of LBBB was >4 times higher with the use of the Medtronic CoreValve System device than with the Edwards SAPIEN device (51% versus 12%). This is the first study indicating the considerable importance of LBBB in the outcome of TAVI patients. More attention should be paid to avoiding LBBB in TAVI procedures, both by implanters and by vendors of TAVI devices. With an approximately 50% rate of LBBB and an approximately 20% rate of permanent pacemaker implantations, the studied Medtronic CoreValve System prostheses (until 2010) performed significantly worse than the Edwards SAPIEN devices with regard to both patient outcome and healthcare costs. LBBB should be regarded as a serious adverse event when evaluating new TAVI devices.
Conclusions: All-cause mortality after TAVI is higher in patients who develop LBBB than in patients who do not. TAVI-induced LBBB is an independent predictor of mortality. 6
A Comprehensive Evaluation of Rhythm Monitoring Strategies for the Detection of Atrial Fibrillation Recurrence: Insights From 647 Continuously Monitored Patients and Implications for Monitoring After Therapeutic Interventions
Summary: Patient follow-up with either short-or long-duration intermittent rhythm monitoring is significantly inferior to that with e269 continuous rhythm monitoring for the detection of atrial fibrillation (AF) recurrence. Intermittent rhythm monitoring strategies fail to identify AF recurrence in a great proportion of patients at risk. Even with feasible, aggressive intermittent monitoring strategies (such as quarterly 24-hour Holter monitoring), AF recurrence will not be identified in a significant proportion of patients. Because of the low sensitivity of intermittent rhythm monitoring, the results of pharmacological or invasive interventions for AF when evaluated with intermittent monitoring should be considered with caution because chance has an immeasurable effect on the detection of AF recurrence, and thus a great proportion of patients will be misclassified, AF recurrence will be underdiagnosed, and therapeutic success will be overestimated. Novel quantitative and temporal AF characteristics (AF burden, AF density) play a major role in AF recurrence detection with the use of intermittent monitoring strategies and may influence clinical parameters and outcomes in AF patients. For accurate patient management, as well as for the scientific, evidencebased evaluation of AF treatments, continuous rhythm monitoring should be strongly recommended.
Conclusions: IRM follow-up is significantly inferior to CM. IRM strategies will not identify AF recurrence in a great proportion of patients at risk. Temporal AF characteristics play a significant role in AF recurrence detection with the use of IRM. For the scientific, evidence-based evaluation of AF treatments, CM should be strongly recommended. Prospective studies are required to evaluate whether CM to guide clinical management can also improve patient outcomes. 7
Physical Activity and Inflammatory Markers Over 10 Years: Follow-Up in Men and Women From the Whitehall II Cohort Study
Summary: The anti-inflammatory effects of exercise are thought to be mechanisms that explain the well-documented cardioprotective effects of physical activity. Although there are abundant crosssectional data relating C-reactive protein and interleukin-6 levels to physical activity, longitudinal data are sparse, and this is a crucial issue for understanding the complex relationships between exercise, weight loss, and inflammation. The present study, which tracked physical activity and inflammatory markers over 10 years of followup in an aging cohort of 4289 men and women, showed that habitually active participants have persistently lower levels of inflammatory markers. In addition, an increase in 2.5 h/wk of moderate to vigorous physical activity through follow-up was associated with lower levels of interleukin-6. The associations observed between physical activity and inflammatory markers were independent of adiposity and changes in body composition. Given that inflammatory markers gradually rise with increasing age and that this proinflammatory status underlies biological mechanisms responsible for cardiovascular disease, physical activity may be regarded as an important factor for the prevention of age-related disease risk.
Conclusions: Regular physical activity is associated with lower markers of inflammation over 10 years of follow-up and thus may be important in preventing the proinflammatory state seen with aging. 8
Multiple Arterial Grafts Improve Late Survival of Patients Undergoing Coronary Artery Bypass Graft Surgery: Analysis of 8622 Patients With Multivessel Disease
Summary: Coronary artery revascularization strategies are evolving: new-generation drug-eluting stents that reduce the need for reintervention, better quantification of types of coronary artery disease that will benefit from stents (SYNTAX score), increased use of stents for multivessel disease, ongoing evaluation of stents for left main disease, new strategies for minimally invasive coronary artery bypass grafting including the use of robots, and hybrid procedures. In comparisons of these strategies, the impact on survival is arguably the most important criterion. It has long been accepted that using the left internal mammary artery to bypass the left anterior descending coronary artery is the gold standard and may confer the survival advantage reported for coronary artery bypass grafting compared with percutaneous coronary intervention in some studies. The survival advantage of additional arterial conduits has been debated. This study, which involved a large cohort of patients with multivessel disease, has shown that in isolated coronary artery bypass grafting performed >15 years ago with the use of left internal mammary artery to the left anterior descending coronary artery, bypassing the non-left anterior descending coronary artery targets with at least 1 additional arterial graft was an independent predictor of survival during the succeeding 15 years. The results were confirmed with both a propensity-matched analysis that includes 1153 patients in each group and a multivariate analysis that is able to control for all differences between the groups because of the power of the large cohort in the series. The significant survival advantage of multiple arterial grafts must be considered in patients with multivessel disease as various revascularization strategies are considered.
Conclusions:
In patients undergoing isolated coronary artery bypass graft surgery with LIMA to left anterior descending artery, arterial grafting of the non-left anterior descending vessels conferred a survival advantage at 15 years compared with SV grafting. It is still unproven whether these results apply to higher-risk subgroups of patients. 9
Cerebral Embolization During Transcatheter Aortic Valve Implantation: A Transcranial Doppler Study
Summary: Neurological events are currently considered one of the most pressing concerns with transcatheter aortic valve implantation (TAVI). A nearly 4-fold risk of such events within 30 days after the procedure was observed for nonoperable patients undergoing TAVI compared with patients treated with optimal medical therapy in cohort B of the Placement of AoRtic TraNscathetER valves (PART-NER) trial, and similar results were found when TAVI was compared with surgical aortic valve replacement in the high-risk population of cohort A. Moreover, a high load of clinically silent embolic lesions was documented on postprocedural cerebral diffusion-weighted MRI, which has raised additional safety concerns. In the present study, serial transcranial Doppler monitoring was performed to elucidate the main source of procedural emboli. During TAVI, high-intensity transient signals were detected in all patients as a surrogate for microembolization. They predominantly occurred during manipulation of the calcified native valve while positioning and implanting the stent valves, with no differences between the transfemoral and the transapical approach and only a trend toward a higher amount of highintensity transient signals for the self-expandable prosthesis. Despite the omnipresence of high-intensity transient signals, however, only 2 (2.4%) neurological complications occurred within 30 days, and there were no late neurological events. However, these findings corroborate the importance of periprocedural embolization during TAVI and reinforce current calls for an increased focus on this issue, especially when TAVI indications are broadened toward younger, lowerrisk patients. Future research is essential to better determine the "real" neurological risk of the TAVI procedure and to thoroughly investigate e270 Circulation January 15, 2013 the feasibility, safety, and efficacy of upcoming strategies to reduce the risk for cerebral embolization, eg, use of less traumatic devices, omission of preparatory valvuloplasty, carotid compression during valve manipulation, or use of active cerebral protection devices.
Conclusions: Procedural HITS were detected by transcranial Doppler in all patients. Although no difference was observed between the transfemoral and the transapical approach with the balloon-expandable ES stent valve, transfemoral TAVI with the self-expandable MCV prosthesis resulted in the greatest number of HITS, predominantly during implantation. 10
Risk of Elective Major Noncardiac Surgery After Coronary Stent Insertion: A Population-Based Study
Summary: For patients with coronary stents, practice guidelines recommend that elective noncardiac surgery be delayed until surgery can be performed safely using antiplatelet therapy with aspirin alone. The suggested delay is 30 to 45 days for bare-metal stents and 1 year for drug-eluting stents. However, these recommendations are largely based on expert opinion and limited data. We therefore conducted a population-based cohort study in Ontario, Canada to describe the risks of major elective noncardiac surgery after stent implantation. After linking population-based administrative databases to a province-wide coronary stent registry, rates of 30-day major adverse cardiac events (mortality, readmission for acute coronary syndrome, repeat coronary revascularization) were measured among patients who underwent major elective noncardiac surgery from 2003 to 2008 after previous stent implantation. We found that when the interval between stent implantation and surgery was <45 days, event rates were high for bare-metal (6.7%) and drug-eluting (20.0%) stents. When the interval was 45 to 180 days, the event rate for baremetal stents was 2.6%, which approached that of nonrevascularized individuals with Revised Cardiac Risk Index scores of 1 to 2. Adjusted analyses suggested this event rate increased further if this interval exceeded 180 days. For drug-eluting stents, the event rate was 1.2% once the interval exceeded 180 days, approaching that of nonrevascularized individuals with Revised Cardiac Risk Index scores of 1. These results suggest that the earliest optimal time for performing major elective noncardiac surgery is 46 to 180 days after bare-metal stent implantation and >180 days after drug-eluting stent implantation.
Conclusions:
The earliest optimal time for elective surgery is 46 to 180 days after bare-metal stent implantation or >180 days after drugeluting stent implantation. 11
Echocardiographic Predictors of Outcome in Eisenmenger Syndrome
Summary: Although echocardiography provides accurate information on cardiac anatomy and physiology, as well as prognosis data in patients with idiopathic pulmonary arterial hypertension, only few data exist on the prognostic power of echocardiographic parameters in adults with Eisenmenger syndrome, which was the subject of this study. Our data from a single center on a large contemporary cohort of adults with Eisenmenger syndrome showed that echocardiographic indices of right ventricular function (tricuspid annular plane systolic excursion, ratio of right ventricular effective systolic to diastolic duration) and right atrial area are predictive of mortality, assessed either alone or even more so in a composite score. Because the assessment of functional class remains difficult, especially in patients with congenital heart disease, we believe that this score may be used in the risk stratification of Eisenmenger patients and could influence the decision to initiate or escalate therapy.
Conclusions: Echocardiographic parameters of right ventricular function and RA area predict mortality in Eisenmenger patients. A new composite echocardiographic score, described herewith, may be incorporated into the noninvasive, periodic assessment of these patients. 12
Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists: Systematic Review and Meta-Analysis of Bleeding and Thromboembolic Rates
Summary: Periprocedural heparin bridging with low-molecularweight heparin (LMWH) in patients on long-term warfarin aims to reduce the risk of thromboembolic events in the immediate periprocedural period. However, although periprocedural anticoagulation remains a common clinical problem, optimal methods have not been established. Recently published international guidelines on antithrombotic therapy recommend an individualized approach to determining the need for bridging anticoagulation based on a patient's estimated thromboembolic risk and periprocedural bleed risk. Using established methods, we conducted a systematic review and metaanalysis of 34 studies (including 1 randomized trial) that used lowmolecular-weight heparin as periprocedural bridging therapy. We used low-thromboembolic-risk groups who did not receive bridging therapy or patients who were not on warfarin for comparators to assess baseline periprocedural thromboembolic and bleed risks. We found a >5-fold increased risk of overall bleeding and >3-fold increased risk of major bleeding associated with the use of bridging therapy, with a similar risk of thromboembolism (including arterial thromboembolism) in bridged and nonbridged patients. There was also an increased risk of overall bleeding when full and prophylactic or intermediate doses of low-molecular-weight heparin bridging were compared. In studies that stratified procedural bleed risk, bleed rates were highest in mostly bridged patients undergoing high-bleed-risk procedures. We concluded that patients on long-term warfarin should avoid routine periprocedural bridging with low-molecular-weight heparin, especially patients not at high thromboembolic risk using therapeutic doses of bridging therapy and undergoing high-bleed-risk procedures. Randomized trials are urgently needed to define the role of periprocedural heparin bridging.
Conclusions: Vitamin K antagonist-treated patients receiving periprocedural heparin bridging appear to be at increased risk of overall and major bleeding and at similar risk of thromboembolic events compared to nonbridged patients. Randomized trials are needed to define the role of periprocedural heparin bridging. 13
Right Ventricular Structure Is Associated With the Risk of Heart Failure and Cardiovascular Death: The Multi-Ethnic Study of Atherosclerosis (MESA)-Right Ventricle Study
Summary: The roles of right ventricular (RV) structure and function in health and disease have not been well studied. Although historical animal studies suggested that the RV did not contribute importantly to cardiac function, more recent studies of patients with diseases such as pulmonary arterial hypertension and congestive heart failure have shown that RV size and ejection fraction are independent predictors of survival. Whether the RV has an important role in community-based adults is unknown. This study showed that the e271 presence of RV hypertrophy (measured by MRI) in adults without clinical cardiovascular disease at baseline was associated with an increased risk of heart failure or cardiovascular death. This association held after accounting for left ventricular mass but was stronger in participants with lower left ventricular mass. There are several explanations for this finding. Patients with left ventricular hypertrophy may have an increased risk of events directly attributable to the left ventricular pathology, explaining why the effect of RV hypertrophy is stronger in its absence. RV hypertrophy could indicate a higher risk of heart failure by serving as a sensitive barometer of left ventricular function. Increased RV afterload may also be seen in conditions such as sleep-disordered breathing and/ or subclinical pulmonary vascular disease, which could cause both RV hypertrophy and an increased risk of events. Alternatively, RV hypertrophy could directly contribute to the onset of heart failure. Clinical cardiovascular disease-free adults with RV hypertrophy are at higher overall risk of heart failure and death, warranting further studies of mechanisms and potential treatment interventions.
Conclusions: RV hypertrophy was associated with the risk of heart failure or death in a multiethnic population free of clinical cardiovascular disease at baseline. 14
Television Watching, Leisure Time Physical Activity, and the Genetic Predisposition in Relation to Body Mass Index in Women and Men
Summary: Sedentary behavior and physical inactivity have independent effects on obesity and related cardiometabolic diseases. Previous studies on gene-lifestyle interaction and obesity have focused mostly on the FTO gene and physical activity, whereas little attention has been paid to sedentary behavior as indicated by television (TV) watching. In 2 prospective cohorts with 7740 women and 4564 men, we calculated a genetic risk score based on 32 established body mass index-associated variants to capture the overall genetic susceptibility and to examine its interactions with leisure time TV watching and physical activity in relation to adiposity. Our results indicate that prolonged TV watching might accentuate the genetic predisposition to elevated adiposity, whereas greater leisure time physical activity might attenuate the genetic association. These findings suggest that deleterious effects of genetic factors could be modified by lifestyle factors and challenge the common lay perception of deterministic genetic predisposition to obesity. Our data provide new information in understanding the interplay between genes and environment and emphasize the important role of both increases in exercise levels and reductions in sedentary behaviors in public health efforts to prevent obesity and related cardiometabolic diseases, particularly in individuals who are more genetically predisposed to obesity.
Conclusions: A sedentary lifestyle, indicated by prolonged TV watching, may accentuate the predisposition to elevated adiposity, whereas greater leisure time physical activity may attenuate the genetic association. 15
Long-Term Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drug Use According to Time Passed After First-Time Myocardial Infarction: A Nationwide Cohort Study
Summary: Recently, there has been much focus on the cardiovascular risk of commonly used nonsteroidal anti-inflammatory drugs (NSAIDs), and the American Heart Association in 2007 published a focused update discouraging the use of NSAIDs in patients with established cardiovascular disease. Despite this, many patients with cardiovascular disease receive NSAIDs. Given the burden posed by NSAIDs after myocardial infarction (MI), it is important to understand the long-term trends in this condition; whether use of NSAID is of greatest risk the first year after the patient's first-time MI and declines as the years pass, or whether use of NSAID changes the declining incidence of cardiovascular risk the years after the MI. In this case, recommendations for long-time caution with these agents may be needed after MI. The current study addresses the risk of all NSAIDs in a selected population of post-MI patients. We present a comprehensive analysis on the effect of time passed following first-time MI NSAID treatment on risk of death or coronary death/ recurrent MI in a nationwide cohort of MI survivors. We found that, that the risk of death and coronary death/recurrent MI remains elevated in NSAID users for up to 5 years after the first MI. Our results indicate that use of NSAIDs is associated with persistently increased coronary risk regardless of time elapsed after MI. Thus, long-term caution with use of NSAIDs is advised in all patients after MI. We believe that these strong messages must be distributed as widely as possible to clinicians taking care of patients with cardiovascular disease.
Conclusions:
The use of NSAIDs is associated with persistently increased coronary risk regardless of time elapsed after first-time MI. We advise long-term caution in the use of NSAIDs for patients after MI. 16
Trends in Antihypertensive Medication Use and Blood Pressure Control Among United States Adults With Hypertension: The National Health and Nutrition Examination Survey, 2001 to 2010
Summary: Trends in antihypertensive medication use and blood pressure control for US adults were examined at a population level during the decade 2001 to 2010 with the use of National Health and Nutrition Examination Survey data. The decade showed significant increases in the percentage of people with hypertension who are treated with medication (from 64% to 77%). Blood pressure control rates have improved from 29% to 47%, and treated control rates have improved from 45% to 60%. Consistent with the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines, significantly more patients with hypertension are on combination therapy now than a decade ago. In addition, the current data indicate that those receiving antihypertensive polytherapy were significantly more likely to meet their blood pressure goals than those who were on monotherapy regimens. Increased usage of multiple antihypertensive drugs has made substantial contributions to the overall control of blood pressure in the general population. This underscores the important role of antihypertensive polytherapy for achieving blood pressure control previously demonstrated in clinical drug trials. Patients whose hypertension is not controlled with monotherapy could benefit from more effective polytherapy regimens. The data also identify key population subgroups that apparently continue to lag behind. Younger adults and Mexican-American people appeared to be undertreated, as did those without health insurance. Older adults and non-Hispanic black people were more likely to be treated, but their hypertension was less likely to be controlled once they were on treatment. The same was true for those with chronic kidney disease and diabetes mellitus. Continued efforts are needed to close these gaps in treatment and to control rates and maximize the public health and clinical benefits of hypertensive therapy. January 15, 2013
Conclusions: Antihypertensive medication use and blood pressure control among US adults with hypertension significantly increased over the past 10 years. Combination therapy regimens can facilitate achievement of blood pressure goals. 17
Association Between Smoke-Free Legislation and Hospitalizations for Cardiac, Cerebrovascular, and Respiratory Diseases: A Meta-Analysis
Summary: Secondhand smoke causes cardiovascular and respiratory disease, and implementation of smoke-free legislation is followed by drops in hospitalizations and deaths from these diseases. This meta-analysis of 45 studies of 33 smoke-free laws found that smoke-free legislation was associated with significantly lower rates of hospital admissions (or deaths) for coronary events, other heart disease, cerebrovascular accidents, and respiratory disease. There was a dose-response relationship between the strength of the law; more comprehensive laws (including workplaces, restaurants, and bars) had the largest health benefits. This study provides strong evidence not only of the health benefits of smoke-free laws, but also of the need to enact comprehensive laws without exceptions.
Conclusions:
Smoke-free legislation was associated with a lower risk of smoking-related cardiac, cerebrovascular, and respiratory diseases, with more comprehensive laws associated with greater changes in risk. 18
Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries: An Analysis of Patients Receiving Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
Summary: The outcome of atrial fibrillation patients on warfarin partially depends on maintaining adequate time in therapeutic International Normalized Ratio (INR) range (TTR). Large differences in TTR have been reported between centers and countries, but the reasons are unclear. In the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial, a warfarin dosing algorithm provided to participating centers recommended no change for inrange and 10% to 15% weekly dose changes for out-of-range INR values. We determined whether algorithm-consistent warfarin dosing could predict patient TTR and the composite outcome of stroke, systemic embolism, or major hemorrhage. Among 6022 nonvalvular atrial fibrillation patients from 44 countries, we found a strong association between the proportion of algorithm-consistent warfarin doses and mean country TTR (R 2 =0.65). The degree of algorithm-consistent warfarin dosing accounted for a majority of the TTR variation between centers and countries. Each 10% increase in center algorithm-consistent dosing independently predicted a 6.12% increase in TTR (95% confidence interval, 5.65-6.59), and an 8% decrease in rate of the composite clinical outcome (hazard ratio, 0.92; 95% confidence interval, 0.85-1.00). In summary, warfarin dosing practice that does not change the dose when the INR is in range, and that makes relatively small (10% to 15%) weekly dose adjustments when the INR is out of range, is associated with improved TTR and clinical outcomes. Systems that implement algorithm-based dosing for patients with atrial fibrillation on warfarin could potentially improve outcomes on a global scale, especially in centers and countries with suboptimal INR control.
Conclusions: Adherence, intentional or not, to a simple warfarin dosing algorithm predicts improved TTR and accounts for considerable TTR variation between centers and countries. Systems facilitating algorithm-based warfarin dosing could optimize anticoagulation quality and improve clinical outcomes in atrial fibrillation on a global scale. 19
Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation:A Systematic Review and Meta-Analysis of the Literature
Summary: Novel oral anticoagulants, including direct thrombin inhibitors and factor Xa inhibitors, have been proposed as alternatives to vitamin K antagonists for the prevention of stroke and systemic embolism in patients with atrial fibrillation. We conducted a systematic review and a meta-analysis of published and unpublished phase II and III randomized, controlled trials comparing the novel oral anticoagulants with the vitamin K antagonists in patients with atrial fibrillation. We retrieved 12 studies (3 administering dabigatran, 4 administering rivaroxaban, 2 administering apixaban, and 3 administering edoxaban) enrolling >50 000 patients. We found that the novel oral anticoagulants significantly reduced overall mortality, cardiovascular mortality, and stroke or systemic embolism. Furthermore, these drugs showed a trend toward reduced major bleeding, with a significant reduction of intracranial hemorrhage. The novel oral anticoagulants may potentially address some of the limitations of vitamin K antagonists because they have fewer food and drug interactions and a more predictable anticoagulant effect, thus allowing fixed-dose regimens without the need for routine laboratory monitoring. Our meta-analysis also provided robust evidence on the overall clinical benefit of the novel oral anticoagulants, suggesting their costeffectiveness in the real-life healthcare systems.
Conclusions: NOACs are associated with an overall clinical benefit compared with vitamin K antagonists. Additional research is required to confirm these findings outside the context of randomized trials. 20
Coronary Artery Bypass Surgery With or Without Mitral Valve Annuloplasty in Moderate Functional Ischemic Mitral Regurgitation: Final Results of the Randomized Ischemic Mitral Evaluation (RIME) Trial
Summary: (CABG) in patients with moderate ischemic mitral regurgitation is uncertain. We randomized 73 patients referred for CABG with moderate ischemic mitral regurgitation and an ejection fraction >30% to receive either CABG plus MVR (34 patients) or CABG only (39 patients). At 1 year, patients in the CABG plus MVR group had a significantly greater improvement in functional capacity as measured by peak oxygen consumption, and greater left ventricular reverse remodeling as measured by the left ventricular end-systolic volume index, reduction in mitral regurgitation severity, and B-type natriuretic peptide levels, compared with the CABG-only group. However, operation duration, blood transfusion, intubation duration, and hospital stay duration were greater in the CABG plus MVR group. There was also a trend toward higher complication rates in the CABG plus MVR group, although this was not statistically significant. Deaths at 30 days and 1 year were similar in both groups, as was the incidence of hospitalization for heart failure. The results of this study support the addition of MVR to CABG in patients with moderate ischemic mitral regurgitation undergoing CABG, but the benefits of the combined procedure must be balanced against a possible increased risk of morbidity in the e273 perioperative period. The impact of the benefits reported in this study on longer term clinical outcomes remains to be defined.
Conclusions:
Adding mitral annuloplasty to CABG in patients with moderate ischemic MR may improve functional capacity, left ventricular reverse remodeling, MR severity, and B-type natriuretic peptide levels, compared with CABG alone. The impact of these benefits on longer term clinical outcomes remains to be defined. 21
Synergistic Adaptations to Exercise in the Systemic and Coronary Circulations That Underlie the Warm-Up Angina Phenomenon
Summary: Patients with angina often find their symptoms are less pronounced on second compared with first exertion. This is known as the warm-up angina phenomenon, and despite being described >200 years ago it remains poorly understood. The symptomatic benefit provided by the first exertion is still discernible with standard antianginal medication and is accompanied by less ST-segment depression and ischemia-induced dysrhythmia. In patients with angina we investigated the changes in central aortic pressure and coronary artery pressure and flow beyond the culprit stenosis during first and second supine effort in the cardiac catheterization laboratory. These recordings show a number of adaptations during second exercise that act in concert to reduce left ventricular afterload and improve coronary artery blood flow. Among the most striking alterations occurring during second exercise are a reduction in augmentation of the central aortic systolic pressure and an increase in the intracoronary pressure wave responsible for accelerating blood flow at the onset of diastole. This pressure wave, known as the backward expansion wave, is dependent both on myocardial vascular tone and rate of relaxation. First exercise triggers adaptive changes within the myocardial and systemic circulations that reduce cardiac work and increase myocardial blood flow during subsequent exercise. These features suggest a novel underlying mechanism that may be harnessed for therapeutic benefit.
Conclusions: On repeat exercise in patients with effort angina, synergistic changes in the systemic and coronary circulations combine to improve vascular-ventricular coupling and enhance myocardial perfusion, thereby potentially contributing to the warm-up angina phenomenon. 22
Relationship Between Healthy Diet and Risk of Cardiovascular Disease Among Patients on Drug Therapies for Secondary Prevention: A Prospective Cohort Study of 31 546 High-Risk Individuals From 40 Countries
Summary: Although healthy diets have been shown to be associated with a lower risk of cardiovascular disease (CVD) in populations without prior CVD, much less is known about those with established CVD. We studied the association between overall diet quality and the recurrence of CVD among 31 546 individuals (age, 66.5±6.2 years) with a history of CVD enrolled in 2 randomized trials, the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET) and the Telmisartan Randomized Assessment Study in ACEI Intolerant Subjects With Cardiovascular Disease (TRANSCEND), from 40 middleand high-income countries. A healthy diet consisted of high intake of fruits, vegetables, whole grains, nuts, and fish relative to meat and eggs. A graded association between diet quality and recurrence of CVD events across all regions and various income levels and across different categories of risk factors and comorbidities was observed. These associations were observed in people receiving proven drug therapies for secondary prevention, suggesting that the benefits of dietary modifications were in addition to those from the medications. These data suggest that at least 20% recurrence of CVD could be avoided by adhering to a healthy diet. Highlighting the importance of healthy eating by health professionals and advising high-risk individuals to improve their diet quality would substantially reduce CVD recurrence beyond drug therapy alone and save lives globally.
Conclusions:
A higher-quality diet was associated with a lower risk of recurrent CVD events among people ≥55 years of age with CVD or diabetes mellitus. Highlighting the importance of healthy eating by health professionals would substantially reduce CVD recurrence and save lives globally. 23
Hypothermia in Comatose Survivors From Out-of-Hospital Cardiac Arrest: Pilot Trial Comparing 2 Levels of Target Temperature
Summary: Comatose survivors from an out-of-hospital cardiac arrest present very high mortality, and survivors frequently recover with severe neurological disabilities. Early studies suggest that therapeutic hypothermia may reduce cerebral damage in this setting. However, the optimal level of cooling remains controversial. With classic cooling methods, it was very difficult to maintain a stable temperature at a particular level, which is now possible with the use of devices with automatic temperature feedback control. To further investigate the optimal target temperature during hypothermia, we conducted a pilot trial comparing cooling at 32°C versus 34°C in comatose survivors of out-of-hospital cardiac arrest. The results suggest that the lower temperature level is safe and may be associated with a better outcome in patients surviving an arrest secondary to a shockable rhythm. This observation merits further investigation in a large clinical trial with different initial rhythms.
Conclusions:
The findings of this pilot trial suggest that a lower cooling level may be associated with a better outcome in patients surviving out-of-hospital cardiac arrest secondary to a shockable rhythm. The benefits observed here merit further investigation in a larger trial in out-of-hospital cardiac arrest patients with different presenting rhythms. 24
Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension: One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial
Summary: Patients with uncontrolled hypertension are at significant risk for cardiovascular events, and a subset of these patients who do not respond to aggressive pharmacological treatment (≥3 antihypertensive drugs including a diuretic) are considered to have treatment-resistant hypertension. It has been shown that activation of the sympathetic nervous system is involved in the pathogenesis and maintenance of hypertension. Renal denervation with the Symplicity catheter is a minimally invasive procedure based on the premise that interruption of renal afferent and efferent nerves with resultant decreased sympathetic outflow to the kidneys will reduce renin release and sodium retention, increase renal blood flow, and lower blood pressure. The Symplicity HTN-2 trial demonstrates that radiofrequency ablation of renal nerves can significantly lower blood pressure in patients with systolic blood pressures >160 mm Hg with no loss of treatment effect through 1 year and thus may provide a safe January 15, 2013 and effective adjunctive therapy for treatment-resistant hypertensive patients. / Clinical Perspective Conclusions: Control patients who crossed over to renal denervation with the Symplicity system had a significant drop in blood pressure similar to that observed in patients receiving immediate denervation. Renal denervation provides safe and sustained reduction of blood pressure to 1 year. 25 
